Cargando…
Apatinib plus retinoic acid as maintenance for children with relapsed stage 4 high-risk neuroblastoma: Two case reports
INTRODUCTION: Metastatic neuroblastoma (NB) is an aggressive malignancy with a poor prognosis. Many patients present with relapsed high-risk NB after undergoing first-line treatment, and there is no standard therapy available in this setting. PATIENT CONCERNS: The present study aimed to present the...
Autores principales: | Jin, Mei, Zhang, Dawei, Zhao, Qian, Zhao, Wen, Huang, Cheng, Wang, Xisi, Duan, Chao, Su, Yan, Ma, Xiaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328982/ https://www.ncbi.nlm.nih.gov/pubmed/32590800 http://dx.doi.org/10.1097/MD.0000000000020896 |
Ejemplares similares
-
Targeted therapy with apatinib in a patient with relapsed small cell lung cancer: A case report and literature review
por: Zhao, Jun, et al.
Publicado: (2017) -
S-1 plus apatinib as first-line palliative treatment for stage IVB gastroesophageal junction adenocarcinoma: A case report and review of the literature
por: Zhang, Chu, et al.
Publicado: (2020) -
Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022) -
Neoadjuvant apatinib plus S-1 in locally advanced pulmonary adenocarcinoma: A case report and review of the literature
por: Zhang, Chu, et al.
Publicado: (2020) -
A pilot clinical study of apatinib plus irinotecan in patients with recurrent high-grade glioma: Clinical Trial/Experimental Study
por: Wang, Lei, et al.
Publicado: (2017)